OBJECTIVES: To explore the cardiovascular risk attributable to menopausal status in a 9-year follow-up, population-based study. METHOD: All middle-aged women who met our eligibility criteria were selected from the Tehran Lipid and Glucose Study cohort. Data were collected by face-to-face interviews, physical examination and biochemical assessments at 3-year intervals. The World Health Organization classification was used to define menopausal status. Cardiovascular events that occurred in the cohort were investigated by a panel of medical specialists. RESULTS: Based on menopausal status, there were no significant differences in cardiovascular disease after adjustment for age, body mass index and other confounders; however, significant relationships between serum concentrations of low density cholesterol and total cholesterol and menopausal status were observed. CONCLUSIONS: Menopause, independent of other cardiovascular disease risk factors, incurred cardiometabolic risk.
OBJECTIVES: To explore the cardiovascular risk attributable to menopausal status in a 9-year follow-up, population-based study. METHOD: All middle-aged women who met our eligibility criteria were selected from the Tehran Lipid and Glucose Study cohort. Data were collected by face-to-face interviews, physical examination and biochemical assessments at 3-year intervals. The World Health Organization classification was used to define menopausal status. Cardiovascular events that occurred in the cohort were investigated by a panel of medical specialists. RESULTS: Based on menopausal status, there were no significant differences in cardiovascular disease after adjustment for age, body mass index and other confounders; however, significant relationships between serum concentrations of low density cholesterol and total cholesterol and menopausal status were observed. CONCLUSIONS: Menopause, independent of other cardiovascular disease risk factors, incurred cardiometabolic risk.
Authors: Ana Carbonell-Baeza; Alberto Soriano-Maldonado; Francisco Javier Gallo; María Puerto López del Amo; Pilar Ruiz-Cabello; Ana Andrade; Milkana Borges-Cosic; Antonio Rubén Peces-Rama; Zuzana Spacírová; Inmaculada C Álvarez-Gallardo; Leticia García-Mochón; Víctor Segura-Jiménez; Fernando Estévez-López; Daniel Camiletti-Moirón; Jose Jesús Martín-Martín; Pilar Aranda; Manuel Delgado-Fernández; Virginia A Aparicio Journal: BMC Public Health Date: 2015-06-17 Impact factor: 3.295
Authors: N Moratalla-Cecilia; A Soriano-Maldonado; P Ruiz-Cabello; M M Fernández; E Gregorio-Arenas; P Aranda; V A Aparicio Journal: Qual Life Res Date: 2016-04-16 Impact factor: 4.147
Authors: Irene Coll-Risco; Pedro Acosta-Manzano; Milkana Borges-Cosic; Daniel Camiletti-Moiron; Pilar Aranda; Alberto Soriano-Maldonado; Virginia A Aparicio Journal: J Clin Med Date: 2019-10-14 Impact factor: 4.241